What is the normal range for the Relative Skeletal Muscle Index (RSMI) in adult women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal RSMI Range for Women

The normal Relative Skeletal Muscle Index (RSMI) for adult women is ≥5.45 kg/m², with values below this threshold indicating severe muscle mass depletion (sarcopenia).

Defining Normal Values

The most clinically relevant cutoff for RSMI in women comes from validated research establishing 5.45 kg/m² as the lower limit of normal 1. This threshold represents the 5th percentile of muscle mass and is calculated as appendicular skeletal muscle mass (ASM) divided by height squared (ASM/height²).

Key Reference Values:

  • Normal RSMI: ≥5.45 kg/m²
  • Severe depletion (sarcopenia): <5.45 kg/m²
  • Alternative definition: Values >2 standard deviations below the mean for young adult reference populations 2, 3

Clinical Context by Population

For cancer patients, the ESPEN guidelines specifically cite <5.45 kg/m² as indicating severe muscle depletion strongly associated with mortality, surgical complications, and chemotherapy toxicity 1.

For general populations, research demonstrates:

  • Korean women: Mean RSMI of 5.9±0.7 kg/m², with cutoff of 4.4 kg/m² (2 SD below mean) 4
  • Japanese women: Similar thresholds with sarcopenia prevalence of 10-30% depending on bone density status 3
  • Western populations: The 5.45 kg/m² threshold remains consistent 2, 5

Measurement Methodology

RSMI should be measured using dual-energy X-ray absorptiometry (DXA) as the reference standard 1, 2. The calculation involves:

  1. Measure appendicular skeletal muscle mass (sum of muscle mass in all four limbs)
  2. Divide by height in meters squared
  3. Compare to threshold of 5.45 kg/m²

Important caveat: Alternative methods exist including CT imaging (lumbar skeletal muscle index <39 cm²/m² for women) and bioelectrical impedance (fat-free mass index <11.4 kg/m² for women), but these use different cutoffs 1.

Age and Menopausal Considerations

The prevalence of sarcopenia increases significantly with age and menopausal status 2, 3, 6:

  • Premenopausal osteopenic women: 12.5% prevalence
  • Postmenopausal osteopenic women: 25% prevalence
  • Postmenopausal osteoporotic women: 50% prevalence

However, the cutoff value of 5.45 kg/m² remains constant across age groups as it is already standardized against young adult reference populations 1.

Clinical Significance

Values below 5.45 kg/m² are independently associated with:

  • 2-3 times greater likelihood of functional impairment and physical disability 5
  • Increased mortality risk in cancer patients 1
  • Higher rates of postoperative complications 1
  • Greater chemotherapy toxicity 1

The relationship between low RSMI and adverse outcomes persists even after adjusting for age, BMI, comorbidities, and other confounding factors 5.

Practical Application

When interpreting RSMI values:

  • ≥5.45 kg/m²: Normal muscle mass
  • <5.45 kg/m²: Severe depletion requiring intervention
  • Borderline values (5.0-5.45 kg/m²): Consider clinical context, physical function testing, and risk factors

Physical activity is the strongest modifiable factor associated with maintaining normal RSMI, more so than diet or hormone replacement therapy 2. Combined nutrition (protein 1.2-1.6 g/kg/day) and resistance exercise interventions are recommended when RSMI falls below normal 7, 1.

References

Research

Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2006

Research

Prevalence of sarcopenia in Japanese women with osteopenia and osteoporosis.

Journal of bone and mineral metabolism, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.